Therapeutic Approach to Autoimmune Neurologic Disorders

Area of Science:

• Neurology
• Immunology
• Neuroimmunology

Background:

• Autoimmune neurologic disorders are characterized by immune system attacks on the central, peripheral, or autonomic nervous systems.
• Over 50 antibodies are now linked to these conditions, with diagnostic capabilities rapidly advancing.
• Therapeutic strategies have historically relied on expert opinion and case studies.

Purpose of the Study:

• To provide comprehensive information on acute and maintenance immunotherapy for autoimmune neurologic disorders.
• To review symptomatic management and special considerations for patient care.
• To discuss the evolving landscape of treatment options, including FDA-approved biologics and ongoing clinical trials.

Main Methods:

• Review of current literature on immunotherapy and symptomatic management.
• Analysis of recent FDA approvals and ongoing clinical trials for autoimmune neurologic disorders.
• Discussion of diagnostic approaches and factors influencing treatment decisions.

Main Results:

• The field has seen significant expansion in identified antibodies and diagnostic tools.
• Biologic agents are now FDA-approved for neuromyelitis optica spectrum disorder and myasthenia gravis.
• Clinical trials are actively investigating new therapeutics for autoimmune encephalitis and other conditions.

Conclusions:

• Early recognition and thorough evaluation are crucial for optimal patient care.
• Treatment requires consideration of disease pathogenesis, immunotherapy mechanisms, and individual patient needs.
• A multidisciplinary approach integrating immunotherapy and symptomatic management is essential.